The life and death of epithelia during inflammation: Lessons learned from the gut

Annual Review of Pathology: Mechanisms of Disease

Volumn 7, Issue , 2012, Pages 35-60

  Koch, Stefan ^a   Nusrat, Asma ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Differentiation; Homeostasis; Inflammatory bowel diseases; Proliferation

Indexed keywords

BETA CATENIN; BETA INTERFERON; BONE MORPHOGENETIC PROTEIN; GAMMA INTERFERON; GLYCOGEN SYNTHASE KINASE 3; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 6; JANUS KINASE; LEUCINE RICH REPEAT CONTAINING G PROTEIN COUPLED RECEPTOR 5; NOGGIN; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN P42; PROTEIN P44; PROTEIN SERINE THREONINE KINASE; SONIC HEDGEHOG PROTEIN; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; WNT PROTEIN;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CARCINOGENESIS; CELL CYCLE REGULATION; CELL DEATH; CELL LINEAGE; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CLOSTRIDIUM DIFFICILE; CYTOKINE PRODUCTION; DNA DAMAGE; DRUG TARGETING; DYSPLASIA; ENTERITIS; EPITHELIUM CELL; FEEDBACK SYSTEM; HOMEOSTASIS; INFLAMMATION; INTESTINE; INTESTINE EPITHELIUM CELL; INTRACELLULAR SIGNALING; MESENCHYME CELL; MOLECULAR INTERACTION; NEOPLASM; OXIDATIVE STRESS; PANETH CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TRICHURIS; TRICHURIS MURIS; WOUND HEALING;

ANIMALS; CYTOKINES; EPITHELIAL CELLS; HOMEOSTASIS; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; SIGNAL TRANSDUCTION;

EID: 84856940669     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev-pathol-011811-120905     Document Type: Review

References (156)

1. Potten CS, Gandara R, Mahida YR, Loeffler M, Wright NA. 2009. The stem cells of small intestinal crypts:Where are they? Cell Prolif. 42:731-50
2. Scoville DH, Sato T, He X.C., Li L. 2008. Current view: intestinal stem cells and signaling. Gastroenterology 134:849-64 (Pubitemid 351312767)
3. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, et al. 2007. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449:1003-7 (Pubitemid 350014593)
4. Spence JR, Mayhew CN, Rankin SA, Kuhar MF, Vallance JE, et al. 2010. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470:105-9
5. MontgomeryRK, CarloneDL, Richmond CA, Farilla L, KranendonkME, et al. 2011. Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc. Natl. Acad. Sci. USA 108:179-84
6. Li L, CleversH. 2010. Coexistence of quiescent and active adult stem cells in mammals. Science 327:542-45
7. de Lau W, Barker N, Clevers H. 2007. WNT signaling in the normal intestine and colorectal cancer. Front. Biosci. 12:471-91 (Pubitemid 46852800)
8. Casali A, Batlle E. 2009. Intestinal stem cells in mammals and Drosophila. Cell Stem Cell 4:124-27
9. Crosnier C, Stamataki D, Lewis J. 2006. Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat. Rev. Genet. 7:349-59
10. Rezza A, Skah S, Roche C, Nadjar J, Samarut J, Plateroti M. 2010. The overexpression of the putative gut stem cell marker Musashi-1 induces tumorigenesis through Wnt and Notch activation. J. Cell Sci. 123:3256-65
11. van Es JH, de Geest N, van de Born M, Clevers H, Hassan BA. 2010. Intestinal stem cells lacking the Math1 tumour suppressor are refractory to Notch inhibitors. Nat. Commun. 1:18
12. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, et al. 2009. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459:262-65
13. Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, et al. 2011. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469:415-18
14. Ootani A, Li X, Sangiorgi E, Ho QT, Ueno H, et al. 2009. Sustained in vitro intestinal epithelial culture within aWnt-dependent stem cell niche. Nat. Med. 15:701-6
15. Andoh A, Bamba S, Fujiyama Y, Brittan M, Wright NA. 2005. Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bonemarrow-derived stem cells to the gut regenerative response. J. Gastroenterol. 40:1089-99 (Pubitemid 43124835)
16. Ramalho-Santos M, Melton DA, McMahon AP. 2000. Hedgehog signals regulate multiple aspects of gastrointestinal development. Development 127:2763-72 (Pubitemid 30426822)
17. Madison BB, Braunstein K, Kuizon E, Portman K, Qiao XT, Gumucio DL. 2005. Epithelial hedgehog signals pattern the intestinal crypt-villus axis. Development 132:279-89 (Pubitemid 40268278)
18. Karlsson L, Lindahl P, Heath JK, Betsholtz C. 2000. Abnormal gastrointestinal development in PDGFA and PDGFR-α deficient mice implicates a novel mesenchymal structure with putative instructive properties in villus morphogenesis. Development 127:3457-66
19. Haramis AP, Begthel H, Van Den Born M, van Es J, Jonkheer S, et al. 2004. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 303:1684-86 (Pubitemid 38338329)
20. Mandir N, FitzGerald AJ, Goodlad RA. 2005. Differences in the effects of age on intestinal proliferation, crypt fission and apoptosis on the small intestine and the colon of the rat. Int. J. Exp. Pathol. 86:125-30 (Pubitemid 40523813)
21. Cheng H, Bjerknes M. 1985. Whole population cell kinetics and postnatal development of the mouse intestinal epithelium. Anat. Rec. 211:420-26 (Pubitemid 15081136)
22. Xiao ZQ, Moragoda L, Jaszewski R, Hatfield JA, Fligiel SE, Majumdar AP. 2001. Aging is associated with increased proliferation and decreased apoptosis in the colonic mucosa. Mech. Ageing Dev. 122:1849-64 (Pubitemid 32835228)
23. Holt PR, Yeh KY, Kotler DP. 1988. Altered controls of proliferation in proximal small intestine of the senescent rat. Proc. Natl. Acad. Sci. USA 85:2771-75
24. Sipos F, Molnar B, Zagoni T, Berczi L, Tulassay Z. 2005. Growth in epithelial cell proliferation and apoptosis correlates specifically to the inflammation activity of inflammatory bowel diseases: ulcerative colitis shows specific p53- and EGFR expression alterations. Dis. Colon Rectum 48:775-86 (Pubitemid 40880726)
25. Serafini EP, Kirk AP, Chambers TJ. 1981. Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut 22:648-52 (Pubitemid 11018268)
26. Noffsinger A, Unger B, Fenoglio-Preiser CM. 1998. Increased cell proliferation characterizes Crohn's disease. Mod. Pathol. 11:1198-203 (Pubitemid 29009330)
27. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, et al. 2003. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J. Immunol. 171:6164-72 (Pubitemid 37467239)
28. Edelblum KL, Yan F, Yamaoka T, Polk DB. 2006. Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflamm. Bowel Dis. 12:413-24
29. Feagins LA, Souza RF, Spechler SJ. 2009. Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat. Rev. Gastroenterol. Hepatol. 6:297-305
30. Renes IB, VerburgM, Van Nispen DJ, Taminiau JA, BullerHA, et al. 2002. Epithelial proliferation, cell death, and gene expression in experimental colitis: alterations in carbonic anhydrase I, mucin MUC2, and trefoil factor 3 expression. Int. J. Colorectal Dis. 17:317-26 (Pubitemid 36067766)
31. Seno H, Miyoshi H, Brown SL, Geske MJ, Colonna M, Stappenbeck TS. 2009. Efficient colonicmucosal wound repair requires Trem2 signaling. Proc. Natl. Acad. Sci. USA 106:256-61
32. Nava P, Koch S, Laukoetter MG, Lee WY, Kolegraff K, et al. 2010. Interferon-γ regulates intestinal epithelial homeostasis through converging α-catenin signaling pathways. Immunity 32:392-402
33. Gayer CP, Basson MD. 2009. The effects of mechanical forces on intestinal physiology and pathology. Cell Signal. 21:1237-44
34. McCormick DA, Horton LW, Mee AS. 1990. Mucin depletion in inflammatory bowel disease. J. Clin. Pathol. 43:143-46 (Pubitemid 20044035)
35. Morson BC. 1972. Rectal biopsy in inflammatory bowel disease. N. Engl. J. Med. 287:1337-39
36. Van Der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, et al. 2006. Muc2-deficient mice spontaneously develop colitis, indicating thatMuc2 is critical for colonic protection. Gastroenterology 131:117-29 (Pubitemid 44015753)
37. Mastroianni JR, Ouellette AJ. 2009. α-Defensins in enteric innate immunity: functional Paneth cell α-defensins in mouse colonic lumen. J. Biol. Chem. 284:27848-56
38. Wehkamp J, Schmid M, Fellermann K, Stange EF. 2005. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. J. Leukoc. Biol. 77:460-65 (Pubitemid 40489521)
39. Sandow MJ, Whitehead R. 1979. The Paneth cell. Gut 20:420-31 (Pubitemid 9212792)
40. Wada R. 2009. Proposal of a new hypothesis on the development of colorectal epithelial neoplasia: nonspecific inflammation-colorectal Paneth cell metaplasia-colorectal epithelial neoplasia. Digestion 79(Suppl. 1):9-12
41. Stappenbeck TS, Miyoshi H. 2009. The role of stromal stem cells in tissue regeneration and wound repair. Science 324:1666-69
42. Brown SL, Riehl TE, Walker MR, Geske MJ, Doherty JM, et al. 2007. Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J. Clin. Investig. 117:258-69 (Pubitemid 46048471)
43. Rodilla V, Villanueva A, Obrador-Hevia A, Robert-Moreno A, Fernandez-MajadaV, et al. 2009. Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer. Proc. Natl. Acad. Sci. USA 106:6315-20
44. Fre S, Pallavi SK, Huyghe M, Lae M, Janssen KP, et al. 2009. Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc. Natl. Acad. Sci. USA 106:6309-14
45. Kitadai Y, Sasaki T, Kuwai T, Nakamura T, Bucana CD, Fidler IJ. 2006. Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth andmetastasis of human colon carcinoma. Am. J. Pathol. 169:2054-65 (Pubitemid 351181965)
46. Beppu H, Mwizerwa ON, Beppu Y, Dattwyler MP, Lauwers GY, et al. 2008. Stromal inactivation of BMPRII leads to colorectal epithelial overgrowth and polyp formation. Oncogene 27:1063-70 (Pubitemid 351253183)
47. Van Dop WA, Heijmans J, Buller NV, Snoek SA, Rosekrans SL, et al. 2010. Loss of Indian hedgehog activates multiple aspects of a wound healing response in themouse intestine. Gastroenterology 139:1665-76
48. Maric I, Poljak L, Zoricic S, Bobinac D, Bosukonda D, et al. 2003. Bone morphogenetic protein 7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats. J. Cell Physiol. 196:258-64 (Pubitemid 36775872)
49. Burke JP, FerranteM, Dejaegher K, Watson RW, DochertyNG, et al. 2008. Transcriptomic analysis of intestinal fibrosis-associated gene expression in response to medical therapy in Crohn's disease. Inflamm. Bowel Dis. 14:1197-204
50. You J, Nguyen AV, Albers CG, Lin F, Holcombe RF. 2008. Wnt pathway-related gene expression in inflammatory bowel disease. Dig. Dis. Sci. 53:1013-19 (Pubitemid 351379836)
51. Hughes KR, Sablitzky F, Mahida YR. 2011. Expression profiling ofWnt family of genes in normal and inflammatory bowel disease primary human intestinal myofibroblasts and normal human colonic crypt epithelial cells. Inflamm. Bowel Dis. 17:213-20
52. Gregorieff A, Pinto D, Begthel H, Destree O, Kielman M, Clevers H. 2005. Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 129:626-38 (Pubitemid 41096648)
53. Lee G, Goretsky T, Managlia E, Dirisina R, Singh AP, et al. 2010. Phosphoinositide 3-kinase signaling mediates α-catenin activation in intestinal epithelial stem and progenitor cells in colitis. Gastroenterology 139:869-81
54. Kaler P, Godasi BN, Augenlicht L, Klampfer L. 2009. The NF-κB/AKT-dependent induction of Wnt signaling in colon cancer cells by macrophages and IL-1α. Cancer Microenviron. 2:69-80
55. He XC, Yin T, Grindley JC, Tian Q, Sato T, et al. 2007. PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat. Genet. 39:189-98 (Pubitemid 46184349)
56. Ghosh S, May MJ, Kopp EB. 1998. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-60 (Pubitemid 28183365)
57. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, et al. 2007. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446:557-61 (Pubitemid 46514732)
58. Chae S, Eckmann L, Miyamoto Y, Pothoulakis C, Karin M, Kagnoff MF. 2006. Epithelial cell IκB kinase has an important protective role in Clostridium difficile toxin A-induced mucosal injury. J. Immunol. 177:1214-20 (Pubitemid 44036626)
59. Zaph C, Troy AE, Taylor BC, Berman-Booty LD, Guild KJ, et al. 2007. Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis. Nature 446:552-56 (Pubitemid 46514719)
60. Tang Y, Clayburgh DR, Mittal N, Goretsky T, Dirisina R, et al. 2010. Epithelial NF-κB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation. Am. J. Pathol. 176:158-67
61. Edelblum KL, Washington MK, Koyama T, Robine S, BaccariniM, PolkDB. 2008. Raf protects against colitis by promoting mouse colon epithelial cell survival through NF-κB. Gastroenterology 135:539-51
62. Otsuka M, Kang YJ, Ren J, Jiang H, Wang Y, et al. 2010. Distinct effects of p38 deletion in myeloid lineage and gut epithelia in mouse models of inflammatory bowel disease. Gastroenterology 138: 1255-65
63. Roy PK, Rashid F, Bragg J, Ibdah JA. 2008. Role of the JNKsignal transduction pathway in inflammatory bowel disease. World J. Gastroenterol. 14:200-2 (Pubitemid 351314299)
64. Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, et al. 2001. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J. Exp. Med. 193:471-81 (Pubitemid 32524478)
65. Bollrath J, Phesse TJ, von Burstin VA, Putoczki T, Bennecke M, et al. 2009. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 15:91-102
66. Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, et al. 2009. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15:103-13
67. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, et al. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10:39-49 (Pubitemid 29077382)
68. Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, et al. 2007. Phosphorylation of α-catenin by AKT promotes α-catenin transcriptional activity. J. Biol. Chem. 282:11221-29 (Pubitemid 47100795)
69. Ashton GH, Morton JP, Myant K, Phesse TJ, Ridgway RA, et al. 2010. Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream ofWnt/c-Myc signaling. Dev. Cell 19: 259-69
70. Oguma K, Oshima H, Aoki M, Uchio R, Naka K, et al. 2008. Activated macrophages promote Wnt signalling through tumour necrosis factor in gastric tumour cells. EMBO J. 27:1671-81
71. Ng SS, Mahmoudi T, Danenberg E, Bejaoui I, de Lau W, et al. 2009. Phosphatidylinositol 3-kinase signaling does not activate the wnt cascade. J. Biol. Chem. 284:35308-13
72. Taelman VF, Dobrowolski R, Plouhinec JL, Fuentealba LC, Vorwald PP, et al. 2010. Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 143: 1136-48
73. Hu D, Bi X, Fang W, Han A, YangW. 2009. GSK3is involved in JNK2-mediatedα-catenin inhibition. PLoS ONE 4:e6640
74. Hu D, Fang W, Han A, Gallagher L, Davis RJ, et al. 2008. c-Jun N-terminal kinase 1 interacts with and negatively regulates Wnt/α-catenin signaling through GSK3 pathway. Carcinogenesis 29:2317-24
75. Tong C, Yin Z, Song Z, Dockendorff A, Huang C, et al. 2007. c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression. Am. J. Pathol. 171:297-303 (Pubitemid 47339246)
76. Thornton TM, Pedraza-Alva G, Deng B, Wood CD, Aronshtam A, et al. 2008. Phosphorylation by p38 MAPK as an alternative pathway for GSK3inactivation. Science 320:667-70 (Pubitemid 351928349)
77. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR. 2000. Requirement for glycogen synthase kinase-3in cell survival and NF-κB activation. Nature 406:86-90 (Pubitemid 30460216)
78. Takada Y, Fang X, JamaluddinMS, Boyd DD, Aggarwal BB. 2004. Genetic deletion of glycogen synthase kinase 3abrogates activation of IκBkinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J. Biol. Chem. 279:39541-54 (Pubitemid 39258221)
79. Bhattacharya S, Ray RM, Johnson LR. 2005. Decreased apoptosis in polyamine depleted IEC-6 cells depends on Akt-mediated NF-κB activation but not GSK3activity. Apoptosis 10:759-76 (Pubitemid 41187075)
80. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. 1999. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82-85
81. Abell K, Bilancio A, Clarkson RW, Tiffen PG, Altaparmakov AI, et al. 2005. Stat3-induced apoptosis requires a molecular switch in PI3K subunit composition. Nat. Cell Biol. 7:392-98 (Pubitemid 40533129)
82. Nateri AS, Spencer-Dene B, Behrens A. 2005. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature 437:281-85 (Pubitemid 41294493)
83. Sancho R, Nateri AS, de Vinuesa AG, Aguilera C, Nye E, et al. 2009. JNK signallingmodulates intestinal homeostasis and tumourigenesis in mice. EMBO J. 28:1843-54
84. Grivennikov SI, Karin M. 2010. Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 21:11-19
85. Deng J, Miller SA, Wang HY, Xia W, Wen Y, et al. 2002. α-Catenin interacts with and inhibits NF-κB in human colon and breast cancer. Cancer Cell 2:323-34 (Pubitemid 41043966)
86. Sun J, Hobert ME, Duan Y, Rao AS, He TC, et al. 2005. Crosstalk between NF-κB and α-catenin pathways in bacterial-colonized intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 289: 129-37
87. Umar S, Sarkar S, Wang Y, Singh P. 2009. Functional cross-talk betweenα-catenin andNF-κB signaling pathways in colonic crypts of mice in response to progastrin. J. Biol. Chem. 284:22274-84
88. ArtisD. 2008. Epithelial-cell recognition of commensal bacteria andmaintenance of immunehomeostasis in the gut. Nat. Rev. Immunol. 8:411-20 (Pubitemid 351733416)
89. Strober W. 2009. The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses. Immunity 31:377-88
90. Duerkop BA, Vaishnava S, Hooper LV. 2009. Immune responses to the microbiota at the intestinal mucosal surface. Immunity 31:368-76
91. Abreu MT. 2010. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 10:131-44
92. Schoenborn JR, Wilson CB. 2007. Regulation of interferon-γ during innate and adaptive immune responses. Adv. Immunol. 96:41-101 (Pubitemid 350018717)
93. Schroder K, Hertzog PJ, Ravasi T, Hume DA. 2004. Interferon-γ: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75:163-89 (Pubitemid 38174573)
94. Mutchnick MG, Lee HH, Hollander DI, Haynes GD, Chua DC. 1988. Defective in vitro interferon production and elevated serum immunoreactive thymosin 4 levels in patients with inflammatory bowel disease. Clin. Immunol. Immunopathol. 47:84-92
95. Ferrier L, Mazelin L, CenacN, Desreumaux P, Janin A, et al. 2003. Stress-induced disruption of colonic epithelial barrier: role of interferon-γand myosin light chain kinase in mice. Gastroenterology 125:795-804 (Pubitemid 37070697)
96. Dignass AU, Podolsky DK. 1993. Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor?. Gastroenterology 105:1323-32 (Pubitemid 23315306)
97. Ito R, Shin-Ya M, Kishida T, Urano A, Takada R, et al. 2006. Interferon-γ is causatively involved in experimental inflammatory bowel disease in mice. Clin. Exp. Immunol. 146:330-38 (Pubitemid 44581349)
98. Tong Q, Vassilieva EV, Ivanov AI, Wang Z, BrownGT, et al. 2005. Interferon-γinhibits T84 epithelial cell migration by redirecting transcytosis of β1 integrin from the migrating leading edge. J. Immunol. 175:4030-38 (Pubitemid 41292066)
99. Chiba H, Kojima T, Osanai M, Sawada N. 2006. The significance of interferon-α-triggered internalization of tight-junction proteins in inflammatory bowel disease. Sci. Signal Transduct. Knowl. Environ. 2006:pe1
100. Ruemmele FM, Gurbindo C, Mansour AM, Marchand R, Levy E, Seidman EG. 1998. Effects of interferon on growth, apoptosis, and MHC class II expression of immature rat intestinal crypt (IEC-6) cells. J. Cell Physiol. 176:120-26 (Pubitemid 28277202)
101. Jarry A, Bossard C, Bou-Hanna C, Masson D, Espaze E, et al. 2008. Mucosal IL-10 and TGF-sβ play crucial roles in preventing LPS-driven, IFN-γ-mediated epithelial damage in human colon explants. J. Clin. Investig. 118:1132-42 (Pubitemid 351364620)
102. Nava P, Laukoetter MG, Hopkins AM, Laur O, Gerner-Smidt K, et al. 2007. Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium. Mol. Biol. Cell 18:4565-78 (Pubitemid 350060182)
103. Sfikakis PP. 2010. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr. Dir. Autoimmun. 11:180-210
104. Corredor J, Yan F, Shen CC, Tong W, John SK, et al. 2003. Tumor necrosis factor regulates intestinal epithelial cell migration by receptor-dependent mechanisms. Am. J. Physiol. Cell Physiol. 284: 953-61
105. Schmitz H, Fromm M, Bentzel CJ, Scholz P, Detjen K, et al. 1999. Tumor necrosis factor (TNFκ) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J. Cell Sci. 112(Part 1): 137-46 (Pubitemid 29043841)
106. Ivanov AI, Parkos CA, Nusrat A. 2010. Cytoskeletal regulation of epithelial barrier function during inflammation. Am. J. Pathol. 177:512-24
107. Fish SM, Proujansky R, Reenstra WW. 1999. Synergistic effects of interferon and tumour necrosis factor on T84 cell function. Gut 45:191-98 (Pubitemid 29333767)
108. Wang F, Schwarz BT, Graham WV, Wang Y, Su L, et al. 2006. IFN-γ-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 131:1153-63 (Pubitemid 44515106)
109. Planchon SM, Martins CA, Guerrant RL, Roche JK. 1994. Regulation of intestinal epithelial barrier function by TGF-β1. Evidence for its role in abrogating the effect of a T cell cytokine. J. Immunol. 153:5730-39 (Pubitemid 24377709)
110. Madsen KL, Lewis SA, Tavernini MM, Hibbard J, Fedorak RN. 1997. Interleukin 10 prevents cytokineinduced disruption of T84 monolayer barrier integrity and limits chloride secretion. Gastroenterology 113:151-59 (Pubitemid 27281769)
111. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, et al. 2001. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121:580-91 (Pubitemid 32822573)
112. Blaschitz C, Raffatellu M. 2010. Th17 cytokines and the gut mucosal barrier. J. Clin. Immunol. 30:196-203
113. Littman DR, Rudensky AY. 2010. Th17 and regulatoryTcells in mediating and restraining inflammation. Cell 140:845-58
114. Raffatellu M, George MD, Akiyama Y, Hornsby MJ, Nuccio SP, et al. 2009. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 5:476-86
115. Kinugasa T, Sakaguchi T, Gu X, Reinecker HC. 2000. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 118:1001-11 (Pubitemid 30346975)
116. Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, et al. 2009. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206:1465-72
117. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, et al. 2006. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290:827-38
118. Serhan CN, Chiang N, Van Dyke TE. 2008. Resolving inflammation: dual anti-inflammatory and proresolution lipid mediators. Nat. Rev. Immunol. 8:349-61 (Pubitemid 351595216)
119. Dufton N, Perretti M. 2010. Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists. Pharmacol. Ther. 127:175-88
120. Babbin BA, Lee WY, Parkos CA, Winfree LM, Akyildiz A, et al. 2006. Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J. Biol. Chem. 281:19588-99 (Pubitemid 44035462)
121. BabbinBA, Jesaitis AJ, Ivanov AI, Kelly D, LaukoetterM, et al. 2007. Formyl peptide receptor 1 activation enhances intestinal epithelial cell restitution through phosphatidylinositol 3-kinase-dependent activation of Rac1 and Cdc42. J. Immunol. 179:8112-21
122. Campbell EL, Louis NA, Tomassetti SE, Canny GO, Arita M, et al. 2007. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J. 21:3162-70 (Pubitemid 47565535)
123. Campbell EL, MacManus CF, Kominsky DJ, Keely S, Glover LE, et al. 2010. Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification. Proc. Natl. Acad. Sci. USA 107:14298-303
124. Crosby LM, Waters CM. 2010. Epithelial repair mechanisms in the lung. Am. J. Physiol. Lung Cell Mol. Physiol. 298:715-31
125. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ. 2009. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9:679-91
126. Blanpain C, Fuchs E. 2009. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat. Rev. Mol. Cell Biol. 10:207-17
127. Suter MM, Schulze K, Bergman W, Welle M, Roosje P, Muller EJ. 2009. The keratinocyte in epidermal renewal and defence. Vet. Dermatol. 20:515-32
128. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. 1995. Inhibition of glycogen synthase kinase 3 by insulin mediated by protein kinase B. Nature 378:785-89 (Pubitemid 26004411)
129. Davies CC, Chakraborty A, Cipriani F, Haigh K, Haigh JJ, Behrens A. 2010. Identification of a coactivator that links growth factor signalling to c-Jun/AP-1 activation. Nat. Cell Biol. 12:963-72
130. Tsuchiya Y, Asano T, Nakayama K, Kato T Jr, Karin M, Kamata H. 2010. Nuclear IKKis an adaptor protein for IκBubiquitination and degradation in UV-induced NF-κB activation. Mol. Cell 39:570-82
131. Al-Sadi RM, Ma TY. 2007. IL-1αcauses an increase in intestinal epithelial tight junction permeability. J. Immunol. 178:4641-49 (Pubitemid 46492417)
132. Varilek GW, Neil GA, Bishop WP. 1994. Caco-2 cells express type I interleukin-1 receptors: Ligand binding enhances proliferation. Am. J. Physiol. Gastrointest. Liver Physiol. 267:1101-7
133. O'Loughlin EV, Pang GP, Noltorp R, Koina C, Batey R, Clancy R. 2001. Interleukin 2 modulates ion secretion and cell proliferation in cultured human small intestinal enterocytes. Gut 49:636-43 (Pubitemid 32989199)
134. Maiuri L, Ciacci C, Auricchio S, Brown V, Quaratino S, Londei M. 2000. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 119:996-1006
135. Dignass AU, Podolsky DK. 1996. Interleukin 2 modulates intestinal epithelial cell function in vitro. Exp. Cell Res. 225:422-29
136. Colgan SP, Resnick MB, Parkos CA, Delp-Archer C, McGuirk D, et al. 1994. IL-4 directly modulates function of a model human intestinal epithelium. J. Immunol. 153:2122-29 (Pubitemid 24256683)
137. Phillips JO, EversonMP, Moldoveanu Z, Lue C, Mestecky J. 1990. Synergistic effect of IL-4 and IFN-γ on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells. J. Immunol. 145:1740-44 (Pubitemid 20336738)
138. McGee DW, Vitkus SJ. 1996. IL-4 enhances IEC-6 intestinal epithelial cell proliferation yet has no effect on IL-6 secretion. Clin. Exp. Immunol. 105:274-77 (Pubitemid 26246945)
139. Schneider MR, Hoeflich A, Fischer JR, Wolf E, Sordat B, Lahm H. 2000. Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett. 151:31-38 (Pubitemid 30155582)
140. Jin X, Zimmers TA, Zhang Z, Pierce RH, Koniaris LG. Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice. Gut 59:186-96
141. Wilson AJ, Byron K, Gibson PR. 1999. Interleukin-8 stimulates themigration of human colonic epithelial cells in vitro. Clin. Sci. 97:385-90 (Pubitemid 29425336)
142. Ma D, Wolvers D, Stanisz AM, Bienenstock J. 2003. Interleukin-10 and nerve growth factor have reciprocal upregulatory effects on intestinal epithelial cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284:1323-29
143. Peterson RL, Bozza MM, Dorner AJ. 1996. Interleukin-11 induces intestinal epithelial cell growth arrest through effects on retinoblastoma protein phosphorylation. Am. J. Pathol. 149:895-902 (Pubitemid 26334173)
144. Orazi A, Du X, Yang Z, Kashai M, Williams DA. 1996. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab. Investig. 75:33-42 (Pubitemid 26250271)
145. Booth C, Potten CS. 1995. Effects of IL-11 on the growth of intestinal epithelial cells in vitro. Cell Prolif. 28:581-94 (Pubitemid 26018248)
146. Heller F, Florian P, Bojarski C, Richter J, Christ M, et al. 2005. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129:550-64 (Pubitemid 41096643)
147. Inoue S, Unsinger J, Davis CG, Muenzer JT, Ferguson TA, et al. IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J. Immunol. 184:1401-9
148. Reinecker HC, MacDermott RP, Mirau S, Dignass A, Podolsky DK. 1996. Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 111:1706-13 (Pubitemid 26404238)
149. Schwartz S, Beaulieu JF, Ruemmele FM. 2005. Interleukin-17 is a potent immuno-modulator and regulator of normal human intestinal epithelial cell growth. Biochem. Biophys. Res. Commun. 337:505-9 (Pubitemid 41429313)
150. Kolinska J, Lisa V, Clark JA, Kozakova H, ZakosteleckaM, et al. 2008. Constitutive expression of IL-18 and IL-18R in differentiated IEC-6 cells: effect of TNF-αand IFN-γ treatment. J. Interferon Cytokine Res. 28:287-96 (Pubitemid 351725301)
151. Dambacher J, Beigel F, Zitzmann K, De Toni EN, Goke B, et al. 2009. The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Gut 58:1207-17
152. Dambacher J, Beigel F, Seiderer J, Haller D, Goke B, et al. 2007. Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease. Gut 56:1257-65 (Pubitemid 47300428)
153. Madara JL, Stafford J. 1989. Interferon-γdirectly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Investig. 83:724-27 (Pubitemid 19061198)
154. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, et al. 2005. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am. J. Physiol. Gastrointest. Liver Physiol. 289:960-68
155. Soderholm JD, Streutker C, Yang PC, Paterson C, Singh PK, et al. 2004. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha. Gut 53:1817-24 (Pubitemid 39556903)
156. Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. 2005. Interferon-γand tumor necrosis factor synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am. J. Pathol. 166:409-19 (Pubitemid 40189038)